ALEXANDRIA, Va., Sept. 10 -- United States Patent no. 12,409,214, issued on Sept. 9, was assigned to Longhorn Vaccines and Diagnostics LLC (Bethesda, Md.).
"Immunogenic antigens" was invented by Jeffrey D. Fischer (Washington), Clara J. Sei (Germantown, Md.), Luke T. Daum (San Antonio) and Gerald W. Fischer (Bethesda, Md.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to composite antigens comprising an antigen obtained or derived from an antigenic epitope of one or more pathogens that induces an immune response in a mammal, an antigen obtained or derived from bacterial cell wall material that induces an immune response in a mammal such as LTA, PNG or LPS, and a T cell stimulating antig...